1. Home
  2. ARWR vs PI Comparison

ARWR vs PI Comparison

Compare ARWR & PI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • PI
  • Stock Information
  • Founded
  • ARWR 2003
  • PI 2000
  • Country
  • ARWR United States
  • PI United States
  • Employees
  • ARWR N/A
  • PI N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • PI Industrial Machinery/Components
  • Sector
  • ARWR Health Care
  • PI Technology
  • Exchange
  • ARWR Nasdaq
  • PI Nasdaq
  • Market Cap
  • ARWR 1.8B
  • PI 1.9B
  • IPO Year
  • ARWR 1993
  • PI 2016
  • Fundamental
  • Price
  • ARWR $13.03
  • PI $100.00
  • Analyst Decision
  • ARWR Buy
  • PI Strong Buy
  • Analyst Count
  • ARWR 11
  • PI 8
  • Target Price
  • ARWR $41.44
  • PI $149.00
  • AVG Volume (30 Days)
  • ARWR 1.6M
  • PI 777.7K
  • Earning Date
  • ARWR 05-12-2025
  • PI 04-23-2025
  • Dividend Yield
  • ARWR N/A
  • PI N/A
  • EPS Growth
  • ARWR N/A
  • PI N/A
  • EPS
  • ARWR N/A
  • PI N/A
  • Revenue
  • ARWR $2,500,000.00
  • PI $363,539,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • PI N/A
  • Revenue Next Year
  • ARWR $64.24
  • PI $26.78
  • P/E Ratio
  • ARWR N/A
  • PI N/A
  • Revenue Growth
  • ARWR N/A
  • PI 21.80
  • 52 Week Low
  • ARWR $9.57
  • PI $60.85
  • 52 Week High
  • ARWR $30.41
  • PI $239.88
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 47.38
  • PI 65.44
  • Support Level
  • ARWR $12.44
  • PI $94.81
  • Resistance Level
  • ARWR $14.97
  • PI $100.22
  • Average True Range (ATR)
  • ARWR 0.74
  • PI 4.30
  • MACD
  • ARWR 0.11
  • PI 2.19
  • Stochastic Oscillator
  • ARWR 37.01
  • PI 91.01

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

Share on Social Networks: